ArticleMaterials today. Bio2025
Nature-derived microneedles with metal-polyphenolic networks encapsulation for chronic soft tissue defects repair: Responding and remodeling the regenerative microenvironment.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Versatile metal-phenolic network structure (MPNs) as advanced delivery platforms for bioactive compounds: The design principles, foundations, applications, and future perspectives.Materials today. Bio · 2026Review
- A dual functional theranostic microneedle patch for immunomodulation and real time monitoring in diabetic wound therapy.Theranostics · 2026Article
- Bletilla striata polysaccharide microneedles with astragaloside Ⅳ loaded ZIF-8 nanoparticles for wound healing and anti-scar treatment.Journal of nanobiotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The treatment outcomes of traditional patches for chronic soft tissue defects (CSTDs) are unsatisfactory in clinical, owing to the lack of intrinsic bioactivities to orchestrate the intricate regenerative process. To tackle this deficiency, nature-derived microneedles (NMs) composed of silk methacrylate and snail mucus are developed in this study. The resultant NMs have excellent mechanical strength and biological adhesiveness, ensuring suture-free but reliable fixation on implanted site. To enhance the intrinsic bioactivities, metal-polyphenolic networks (MPNs) coordinated from copper (Cu) and curcumin (Cur) are designed and encapsulated into NMs. Cu-Cur MPNs harness the anti-oxidative and anti-inflammatory properties of Cur with the pro-angiogenic properties of Cu, targeting different negative aspects in CSTDs repair. Furthermore, the pH-responsive disassembly of Cu-Cur MPNs can respond to the acidic microenvironment, allowing for burst-free and on-demand drug delivery. Both in-vitro and in-vivo experiments demonstrate that NMs with Cu-Cur MPNs encapsulation (Cu-Cur-NMs) can restore redox homeostasis, reduce inflammatory response, and promote blood vessel formation, thus remodeling the regenerative microenvironment to greatly improve the repair quality of CSTDs. Therefore, the combined advantages of microneedles-based patch system and MPNs-based nanotherapeutic agent are explored for the first time, and our proposed Cu-Cur-NMs represent a multifunctional and promising device for CSTDs repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.